Atezolizumab is associated with enhanced response in triple-negative breast cancerMay 16, 2023Breast CancerOncology
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Lung CancerOncologyBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
Primary Hepatic Lymphoma: A Rare Form of Diffuse Large B-Cell Lymphoma of the LiverMay 9, 2023Oncology
